Single-ventricle
34
11
12
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
2 terminated out of 34 trials
88.9%
+2.3% vs benchmark
3%
1 trials in Phase 3/4
25%
4 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (34)
Venous Compression in Fontan
Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy
Fibrosis and the Fontan
Re-Energize Fontan
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis
Fontan Fitness Trial
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
PK/PD of Digoxin in Infants With SVHD
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
Ventripoint Single Ventricle Study
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Simple Non-invasive Breathing Device to Improve Pulmonary Flow Pusatility in Single Ventricle Post Fontan
Virtual Remote Physiological Monitoring Program of Children With Heart Disease
Use of Vasopressin Following the Fontan Operation
Association of Near Infrared Spectroscopy With Interstage Outcomes
Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
Inspiratory Muscle Therapy in Subjects With Fontan Circulations